Financial comparisons Imunon, Inc.

Equities

IMNN

US15117N6022

Biotechnology & Medical Research

Delayed Nasdaq 04:00:00 2025-01-17 pm EST 5-day change 1st Jan Change
0.9131 USD +1.68% Intraday chart for Imunon, Inc. +1.47% -3.88%
Main competitors
Add to a list
Revenues Net margin Operating Margin ROE ROA Leverage (Debt/EBITDA)
9,869,200,000.00 +36.68%+44.33%22.99x17.71x-2.46x
13,117,200,000.00 +30.14%+39.08%20.74x16.2x-1.6x
1,205,014,160.75 -23.26%-33.51%-8.54x-7.69x10.14x
3,930,225,378.20 +24.36%+18.08%4.62x4.02x-13.1x
2,458,779,000.00 -35.86%-49.12%-22.26x-14.47x2.05x
5,507,352,575.46 +26.50%+29.43%18.99x15.45x-0.64x
1,887,100,000.00 +13.23%+13.30%12.68x8.89x-5.76x
2,273,163,179.56 +26.42%+32.30%14.78x13.31x-5.01x
305,208,000.00 -245.59%-232.51% - -50.2x-0.8x
1,243,336,000.00 -43.11%-21.54%-86.15x-1.86x1.96x
1,830,208,000.00 +11.35%+9.34%8.74x6.91x-5.06x
2,325,527,310.95 +19.96%+24.97%9.02x6.41x-0.78x
274,485,952.45 -180.51%-170.79%-818.43x-50.27x-0.33x
155,346,406.62 -12.22%-37.48%-3.46x-2.93x11.91x
47,299,566.59 -205.30%-166.94%-58.43x - 2.98x
617,926,934.16 +44.81%+45.26%55.36x27.64x0.65x
Average 2,940,460,779.05 -32.02% -28.49% -55.29x -0.73x -0.37x
Weighted average by Cap. 6,329,674,172.22 +0.65% +4.12% -8.03x 6.39x -1.00x
Bio Therapeutic Drugs